Growth Stocks To Watch Today - June 27th
Circle Internet Group, Blackstone, Novo Nordisk A/S, BlackRock, and SpringWorks Therapeutics are the five Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies expected to achieve revenue and earnings growth significantly above the overall market average. These firms typically reinvest profits into research, development, and expansion rather than paying dividends, leading to higher valuation multiples such as price-to-earnings ratios. Investors buy growth stocks primarily for capital appreciation, accepting greater volatility and risk in exchange for the potential of outsized returns. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Founded in 2013, Circle’s mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.
Circle Internet Group stock traded down $23.68 during mid-day trading on Friday, hitting $189.95. The company had a trading volume of 29,260,960 shares, compared to its average volume of 48,468,875. Circle Internet Group has a 1 year low of $64.00 and a 1 year high of $298.99. The firm has a market capitalization of $42.27 billion and a P/E ratio of -15,011.06.
Read Our Latest Research Report on CRCL
Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.
Shares of Blackstone stock traded up $4.01 on Friday, hitting $152.19. The stock had a trading volume of 2,614,043 shares, compared to its average volume of 3,816,486. The company’s 50 day moving average price is $138.24 and its 200 day moving average price is $152.90. The stock has a market cap of $111.04 billion, a price-to-earnings ratio of 45.83, a P/E/G ratio of 1.32 and a beta of 1.65. Blackstone has a 52-week low of $115.66 and a 52-week high of $200.96. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.67.
Read Our Latest Research Report on BX
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
NYSE:NVO traded up $0.84 during trading hours on Friday, reaching $68.54. 3,049,028 shares of the company’s stock were exchanged, compared to its average volume of 7,193,607. Novo Nordisk A/S has a 1-year low of $57.00 and a 1-year high of $145.99. The company has a quick ratio of 0.56, a current ratio of 0.74 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $306.01 billion, a price-to-earnings ratio of 20.32, a P/E/G ratio of 1.20 and a beta of 0.66. The company has a 50-day moving average of $68.90 and a 200 day moving average of $77.56.
Read Our Latest Research Report on NVO
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
Shares of BLK traded up $13.26 during mid-day trading on Friday, hitting $1,044.05. 194,934 shares of the company’s stock were exchanged, compared to its average volume of 691,609. The company has a current ratio of 4.34, a quick ratio of 4.34 and a debt-to-equity ratio of 0.38. BlackRock has a fifty-two week low of $773.74 and a fifty-two week high of $1,084.22. The business’s 50 day moving average is $958.92 and its two-hundred day moving average is $969.49. The firm has a market capitalization of $161.75 billion, a P/E ratio of 25.34, a P/E/G ratio of 3.09 and a beta of 1.41.
Read Our Latest Research Report on BLK
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.
Shares of NASDAQ SWTX traded down $0.01 during mid-day trading on Friday, hitting $46.99. 3,736,788 shares of the company were exchanged, compared to its average volume of 2,497,549. SpringWorks Therapeutics has a 1-year low of $28.21 and a 1-year high of $62.00. The firm has a market cap of $3.54 billion, a price-to-earnings ratio of -13.78 and a beta of 0.70. The stock has a 50 day simple moving average of $45.87 and a 200-day simple moving average of $44.11.
